Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Sarcoma
Volume 3, Issue 1, Pages 33-35
http://dx.doi.org/10.1080/13577149977848

Hypercalcemia Caused by Metastatic Adamantinoma: Response to Radiotherapy

1Department of Radiation Oncology, The Cleveland Clinic Foundation, Cleveland 44195, Ohio, USA
2Department of Hematology Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

Copyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose. To describe successful palliation of a patient with metastatic adamantinoma presenting with lung metastases and hypercalcemia resulting from a parathormone-like substance released from the tumor.

Methods and materials. The records of a patient with a history of a tibial adamantinoma who presented with symptoms of hypercalcemia 20 years after the original surgery, as well as the literature concerning hypercalcemia and adamantinoma were reviewed and summarized.

Results. After thorough review of the literature we found no prior reports of radiation being used for palliation of hypercalcemia associated with metastatic adamantinoma.We report rapid improvement in symptoms and normalization of serum calcium levels following a course of radiation therapy. The patient remains asymptomatic 15 months following radiotherapy despite a gradual return of elevated serum calcium levels.

Discussion. Radiation therapy should be considered as a palliative option for patients who are not surgical candidates presenting with medically refractory hypercalcemia.